loading...| Preferred Name |
drug development tool |
|
| Synonyms |
|
|
| Definitions |
A biomarker, clinical outcome assesment, or any other method, material, or measure determined to aid drug development and regulatory review (FD&C Act, section 507(e)(5)). |
|
| ID |
http://purl.obolibrary.org/obo/bmo.owl/BMO_0000030 |
|
| definition |
A biomarker, clinical outcome assesment, or any other method, material, or measure determined to aid drug development and regulatory review (FD&C Act, section 507(e)(5)). |
|
| definition_source | ||
| label |
drug development tool |
|
| note |
A biomarker, clinical outcome assesment, or any other method, material, or measure determined to aid drug development and regulatory review (FD&C Act, section 507(e)(5)). |
|
| preferred label |
drug development tool |
|
| prefixIRI |
bmo:BMO_0000030 |
|
| prefLabel |
drug development tool |
|
| see also | ||
| textual definition |
A biomarker, clinical outcome assesment, or any other method, material, or measure determined to aid drug development and regulatory review (FD&C Act, section 507(e)(5)). |
|
| subClassOf |